Sustained JNK1 activation is associated with altered histone H3 methylations in human liver cancer - Test2 - elhamkhani - TriplyDB

Sustained JNK1 activation is associated with altered histone H3 methylations in human liver cancer

Sustained JNK1 activation is associated with altered histone H3 methylations in human liver cancer

http://www.wikidata.org/entity/Q24170091

about

sameAs

JNK1 activation predicts the prognostic outcome of the human hepatocellular carcinoma CD95 promotes tumour growth Regulatory Roles of MAPK Phosphatases in Cancer Metabolic derivatives of alcohol and the molecular culprits of fibro-hepatocarcinogenesis: Allies or enemies?Targeting RTK Signaling Pathways in Cancer Pathogenesis of hepatocarcinogenesis in non-cirrhotic nonalcoholic fatty liver disease: Potential mechanistic pathways Advances in hepatocellular carcinoma: Nonalcoholic steatohepatitis-related hepatocellular carcinoma Smad3 phospho-isoform signaling in hepatitis C virus-related chronic liver diseases JNK signalling in cancer: in need of new, smarter therapeutic targets Structural and functional analysis of the natural JNK1 inhibitor quercetagetin Hepatocellular carcinoma in patients with non-alcoholic fatty liver disease RNAi screening with shRNAs against histone methylation-related genes reveals determinants of sorafenib sensitivity in hepatocellular carcinoma cells Molecular classification and novel targets in hepatocellular carcinoma: recent advancements From hepatitis to hepatocellular carcinoma: a proposed model for cross-talk between inflammation and epigenetic mechanisms Hepatitis B virus alters the antioxidant system in transgenic mice and sensitizes hepatocytes to Fas signaling Molecular mechanisms of liver injury and hepatocarcinogenesis: focusing on the role of stress-activated MAPK NF-κB, JNK, and TLR Signaling Pathways in Hepatocarcinogenesis Protein kinase R modulates c-Fos and c-Jun signaling to promote proliferation of hepatocellular carcinoma with hepatitis C virus infection Inflammation- and stress-related signaling pathways in hepatocarcinogenesis Reconstruction of Tissue-Specific Metabolic Networks Using CORDA Mdig de-represses H19 large intergenic non-coding RNA (lincRNA) by down-regulating H3K9me3 and heterochromatin Dickkopfs and Wnt/β-catenin signalling in liver cancer Endoplasmic reticulum stress activates the hepatic activator protein 1 complex via mitogen activated protein kinase-dependent signaling pathways A liver full of JNK: signaling in regulation of cell function and disease pathogenesis, and clinical approaches The potential interplay of adipokines with toll-like receptors in the development of hepatocellular carcinoma JNK-dependent Stat3 phosphorylation contributes to Akt activation in response to arsenic exposure Comparative effects of 4-phenyl-3-butenoic acid and vorinostat on cell growth and signaling JNK and STAT3 signaling pathways converge on Akt-mediated phosphorylation of EZH2 in bronchial epithelial cells induced by arsenic MAPK signaling in inflammation-associated cancer development JNK-induced apoptosis, compensatory growth, and cancer stem cells Hepatocellular carcinoma in non-alcoholic steatohepatitis: Growing evidence of an epidemic?Non-alcoholic fatty liver disease-related hepatocellular carcinoma: a sleeping tiger in the Asia Pacific.The role of macrophages in obesity-driven chronic liver disease.Metformin inhibits the invasion of human hepatocellular carcinoma cells and enhances the chemosensitivity to sorafenib through a downregulation of the ERK/JNK-mediated NF-κB-dependent pathway that reduces uPA and MMP-9 expression.Dynamic changes in chromatin conformation at the TNF transcription start site in T helper lymphocyte subsets.Type 2 Diabetes and Hepatocellular Carcinoma: Risk Factors and Pathogenesis.Molecular analysis of oncogenicity of the transcription factor, BRN3A, in cervical cancer cells.Hepatocellular Carcinoma in the Setting of Non-cirrhotic Nonalcoholic Fatty Liver Disease and the Metabolic Syndrome: US Experience.Evaluation of the p-AKT, p-JNK and FoxO3a function in oral epithelial dysplasia.Role of C-Jun N-terminal Kinase in Hepatocellular Carcinoma Development.

P2860

Q23919676-EBD40372-279A-427A-A018-3E54664C338F Q24602589-63533181-DA26-4C02-BB50-A0A40D10413C Q26751025-B12836FF-9ECA-4726-B835-CBE45E16D657 Q26769611-B27913C2-2788-4818-A001-64EFCE27D82B Q26781278-1A130499-2A88-4AD1-98B9-FEDFF87DAD38 Q26783372-365F1529-8A62-4479-817C-B7C20280D8ED Q26795529-7D4E0295-B0F3-42DA-83FF-6EC682618A35 Q26863522-C2288CDD-567F-4888-9C26-C5C9D843DA46 Q27023869-D799EAC9-3B7C-4401-9D75-92D5052F0BD9 Q27675046-921DEC78-DA46-4507-940B-C330C882191D Q28066100-982F98E1-39D1-43DC-B2BE-7EFA3FEB722D Q28383116-50B4AAFE-AC28-4256-AD3C-51772210D411 Q28383646-DB15233B-89A5-4B95-947A-5C1D0F9F552A Q28383729-09A5606E-A4DA-4CC8-A584-ADD998DABEB0 Q28384324-FEE44EA7-C05C-4184-840B-2A9F73321271 Q28384866-105E03F8-7927-4BEF-9591-CC36B3BC853A Q28384956-F8386FC7-620D-492D-A4BA-08DFF5302D14 Q28385007-F6ED381E-5EAF-40DD-9A51-A4917470A5B9 Q28387669-23BE8A75-AE5C-4CC2-A362-A4567B3842D8 Q28388815-0AB6CBBE-B825-4934-91EB-ADF69A1D1560 Q28390853-9A24BBF8-DA63-4FE4-9571-313EF49C8609 Q28391394-8FC3AC7D-ECCF-49FF-9682-80765EB82DB9 Q28391490-18F96AFF-F82B-4CFC-99FA-EB92496B3E1E Q28392033-2DB273F3-D877-446D-957E-24E70564DDAC Q28392224-DB93912B-795F-47B9-A105-FC977CBA2F61 Q28392308-978A12B9-1D89-4153-A6CB-8BC92BA8A4EE Q28392529-E69E4826-2321-4137-8E9A-614D4B1E250A Q28394303-92E2D32F-0CCA-4F60-AB84-1BB8147DE011 Q28394852-B9794BDD-C017-4F38-985B-48A5920BA694 Q28395713-32DADD6B-90EE-4705-B3FD-83451F348BB0 Q37932057-D87256BD-FA95-46F7-8C66-5B293E06CA1B Q38552383-8EF7D178-A034-4D9B-BC46-B4A4BABCCA81 Q38758810-A03AAEFD-B7F6-4427-ACDB-7E12FC1A32FC Q38954232-B1ADE752-AFB9-4234-A4C8-12564C753199 Q39099558-15F74B70-A8A7-465E-A627-E1610B19BE7C Q39177080-C9020FF3-1167-4D87-AB51-7A54650673CC Q39472062-86B2E4A9-5B98-46C0-AB1B-6B41C773BF13 Q41506217-95FD451C-4CBE-4313-844B-2F0D68ABB754 Q48152752-D05E2669-E0FE-48A7-9679-B20250E857AA Q51653926-A3857098-F263-4CEE-A170-0144798C4419

P2860

Sustained JNK1 activation is associated with altered histone H3 methylations in human liver cancer

http://www.wikidata.org/entity/Q24170091

description

2009 nî lūn-bûn

@nan

2009 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Sustained JNK1 activation is a ...... ylations in human liver cancer

@ast

Sustained JNK1 activation is a ...... ylations in human liver cancer

@en

Sustained JNK1 activation is a ...... ylations in human liver cancer

@en-gb

Sustained JNK1 activation is a ...... ylations in human liver cancer

@nl

type

label

Sustained JNK1 activation is a ...... ylations in human liver cancer

@ast

Sustained JNK1 activation is a ...... ylations in human liver cancer

@en

Sustained JNK1 activation is a ...... ylations in human liver cancer

@en-gb

Sustained JNK1 activation is a ...... ylations in human liver cancer

@nl

prefLabel

Sustained JNK1 activation is a ...... ylations in human liver cancer

@ast

Sustained JNK1 activation is a ...... ylations in human liver cancer

@en

Sustained JNK1 activation is a ...... ylations in human liver cancer

@en-gb

Sustained JNK1 activation is a ...... ylations in human liver cancer

@nl

P1433

Q24170091-705E9A4C-1F16-4AC4-803A-D866DB601C2E

P1476

Q24170091-CD80C4D8-2A9C-428A-86FF-8D9C3B2A4290

P2093

Q24170091-18B8A2D8-491D-415E-8530-E4CAAC75A4FA

Q24170091-A15FDD38-0E95-4D96-B4F8-C44A58919519

Q24170091-A818A97F-CBE6-4AE4-911B-07537B54EAA7

Q24170091-AC52FA3F-6E52-45E2-8DF0-D51BC80576B5

Q24170091-B7E3A16E-403E-4795-82B1-C350E4C282F0

Q24170091-F6153468-1A23-448E-A65B-2F6CE92B14FA

Q24170091-F8737DED-068C-4C23-9771-662FEC7A0000

P2860

Q24170091-0BC53A69-92EE-44ED-9763-6064798A9497

Q24170091-12232FC5-78A8-4BAA-A8D5-EB27958B5950

Q24170091-17C47236-5FC9-4DC9-B530-3470BF75D194

Q24170091-2DCEEE7E-F228-4D64-A2A1-708A0CBF1816

Q24170091-41EFC4BB-1526-4A4B-AF28-DC8CB72ADDE0

Q24170091-4291F035-E25F-4012-A56A-59CDADBE0557

Q24170091-4DDEE668-F96E-473E-8ABE-B078F7FCEDC6

Q24170091-4E6BDCF9-A488-49B9-8035-8D692F5B98F0

Q24170091-51919858-F00B-4242-8DF0-8A9596CE2477

Q24170091-5716A1EB-0AF3-47A6-ADD9-2214F7C48959

P2880

Q24170091-0284F3FF-D4B1-479C-8643-D524F9017F8E

P304

Q24170091-E2DF0665-4A83-4197-8B6E-2113CC096579

P31

Q24170091-8F5D529E-F07A-44A9-B7DF-A5264FD32DB2

P3181

Q24170091-FB4CB1BD-0A12-41E4-8E54-1C9F35E376BA

P356

Q24170091-32A24A44-4E0D-4114-8623-5CCECD1740F6

P407

Q24170091-2C0ECC20-BCDD-4118-9060-B771A955BCF4

P433

Q24170091-B0CEE4A3-57DA-48BE-A582-C5C947BEED7D

P478

Q24170091-F447BD54-0FDB-4E4D-A8B8-3411F655C901

P50

Q24170091-9005BCBD-DE44-41AB-8865-7FC48787298F

Q24170091-BAB10D68-FCE2-4280-B5BB-87E3D7B4C92C

P577

Q24170091-3216D8D8-3C28-430A-92D2-7EDEE15DBA4B

P698

Q24170091-FF85DCDB-8E86-47E3-8CD4-06F94C6E3EBB

P859

Q24170091-1D88A8C2-5554-4EA1-A60F-21BA639B153B

P921

Q24170091-0C83B540-C4CA-470F-BED2-1595ABEB1D4A

Q24170091-12769247-BFA9-4649-96F8-0875256EC765

Q24170091-50874169-C4FA-415A-A190-04A4DCF2ADCA

Q24170091-6978ABB4-04E2-43B9-B034-4FA6665DDF9C

Q24170091-E389731C-DB97-4C12-B02F-D0B20A805CEE

P932

Q24170091-7EFC84F9-6E2B-439C-8A45-A6752092972E

P3181

P356

J.JHEP.2008.07.037

P1433

Journal of Hepatology

P1476

Sustained JNK1 activation is a ...... ylations in human liver cancer

@en

P2093

Deepak Bhatia

http://www.w3.org/2001/XMLSchema#string

Fei Chen

http://www.w3.org/2001/XMLSchema#string

Hongwen Zhao

http://www.w3.org/2001/XMLSchema#string

Jianguo Chen

http://www.w3.org/2001/XMLSchema#string

Kevin J Beezhold

http://www.w3.org/2001/XMLSchema#string

Qingshan Chang

http://www.w3.org/2001/XMLSchema#string

Yadong Zhang

http://www.w3.org/2001/XMLSchema#string

P2860

JNKK1 organizes a MAP kinase module through specific and sequential interactions with upstream and downstream components mediated by its amino-terminal extension

Opposite effect of NF-kB and c-Jun N-terminal kinase on p53-independent GADD45 induction by arsenite

Loss of IkkB promotes migration and proliferation of mouse embryo fibroblast cells

Inhibitor of nuclear factor kB kinase deficiency enhances oxidative stress and prolongs c-Jun NH2-terminal kinase activation induced by arsenic

Nucleolin links to arsenic-induced stabilization of GADD5alpha mRNA

Identification and validation of oncogenes in liver cancer using an integrative oncogenomic approach

EZH2 is a marker of aggressive breast cancer and promotes neoplastic transformation of breast epithelial cells

Methylation profiling of twenty promoter-CpG islands of genes which may contribute to hepatocellular carcinogenesis.

Distinct and predictive chromatin signatures of transcriptional promoters and enhancers in the human genome

Genetic and epigenetic alterations of DLC-1 gene in hepatocellular carcinoma

P2880

20034940

http://www.w3.org/2001/XMLSchema#string

P304

323-33

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

2009993

http://www.w3.org/2001/XMLSchema#string

P356

10.1016/J.JHEP.2008.07.037

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

50

http://www.w3.org/2001/XMLSchema#string

P50

Vincent Castranova

P577

2009-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19041150

http://www.w3.org/2001/XMLSchema#string

P859

National Institute for Occupational Safety and Health

P921

P932

4417500

http://www.w3.org/2001/XMLSchema#string